In this context, H. pylori–associated inflammation characterized by elevated levels of C-reactive protein (CRP), TNF-α, and IL-6 impair hepatic insulin signaling and contribute to disease progression in MASLD [80]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.